drugset / Trial / NCT00425204
Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment
Non-randomizedParallel-groupOpen-labelTreatment
Summary
A multi-center, open-label, extended treatment, clinical trial examining the safety of administering multiple does of panitumumab by intravenous (i.v.) infusion to patients who have previously received panitumumab and benefited from treatment
Timeline
- Start
- 2004-03
- Primary completion
- 2007-09
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Panitumumab | Monoclonal antibody | 2.5 mg/kg | Intravenous |
| Subject | Panitumumab | Monoclonal antibody | 6 mg/kg | Intravenous |
| Subject | Panitumumab | Monoclonal antibody | 9 mg/kg | Intravenous |